Jane Street Group LLC Acquires 754,395 Shares of Enhabit, Inc. (NYSE:EHAB)

Jane Street Group LLC lifted its stake in shares of Enhabit, Inc. (NYSE:EHAB) by 514.3% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 901,084 shares of the company’s stock after acquiring an additional 754,395 shares during the period. Jane Street Group LLC owned 1.79% of Enhabit worth $7,119,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of EHAB. SummerHaven Investment Management LLC boosted its position in shares of Enhabit by 2.8% during the 2nd quarter. SummerHaven Investment Management LLC now owns 61,508 shares of the company’s stock worth $549,000 after purchasing an additional 1,660 shares in the last quarter. Bank of New York Mellon Corp boosted its holdings in Enhabit by 1.5% in the second quarter. Bank of New York Mellon Corp now owns 400,575 shares of the company’s stock worth $3,573,000 after acquiring an additional 5,936 shares in the last quarter. Allspring Global Investments Holdings LLC grew its stake in Enhabit by 1,119.6% in the second quarter. Allspring Global Investments Holdings LLC now owns 45,832 shares of the company’s stock valued at $409,000 after acquiring an additional 42,074 shares during the period. Paradice Investment Management LLC increased its holdings in shares of Enhabit by 0.7% during the second quarter. Paradice Investment Management LLC now owns 1,525,037 shares of the company’s stock valued at $13,603,000 after acquiring an additional 11,128 shares in the last quarter. Finally, Los Angeles Capital Management LLC acquired a new position in shares of Enhabit during the second quarter worth approximately $220,000.

Wall Street Analyst Weigh In

A number of analysts have commented on EHAB shares. Jefferies Financial Group upgraded shares of Enhabit from a “hold” rating to a “buy” rating and boosted their price target for the company from $8.25 to $9.50 in a research note on Monday, December 9th. Leerink Partners restated a “market perform” rating and issued a $8.00 target price (down previously from $8.50) on shares of Enhabit in a report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the stock. According to MarketBeat.com, Enhabit has a consensus rating of “Hold” and a consensus price target of $8.75.

Insider Buying and Selling

In related news, Director Stuart M. Mcguigan purchased 15,000 shares of the firm’s stock in a transaction dated Tuesday, December 10th. The stock was bought at an average price of $8.81 per share, for a total transaction of $132,150.00. Following the purchase, the director now directly owns 46,810 shares in the company, valued at approximately $412,396.10. This trade represents a 47.15 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Jeffrey Bolton acquired 4,000 shares of the company’s stock in a transaction that occurred on Thursday, December 12th. The stock was purchased at an average price of $8.69 per share, for a total transaction of $34,760.00. Following the purchase, the director now owns 98,144 shares of the company’s stock, valued at $852,871.36. The trade was a 4.25 % increase in their position. The disclosure for this purchase can be found here. 1.90% of the stock is currently owned by corporate insiders.

Enhabit Stock Performance

NYSE EHAB opened at $8.52 on Friday. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46. The company has a fifty day moving average price of $7.56 and a 200-day moving average price of $8.31. Enhabit, Inc. has a 1 year low of $6.85 and a 1 year high of $11.74. The firm has a market cap of $428.42 million, a price-to-earnings ratio of -3.67 and a beta of 1.89.

Enhabit (NYSE:EHAB) last posted its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The firm had revenue of $253.60 million during the quarter, compared to analysts’ expectations of $261.69 million. During the same quarter last year, the business posted $0.03 EPS. As a group, equities research analysts predict that Enhabit, Inc. will post 0.22 EPS for the current fiscal year.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.